Improving properties of recombinant SsoPox by site-specific pegylation

Protein and Peptide Letters

Volumn 22, Issue 12, 2015, Pages 1098-1103

  Parikh, Harsh ^a   Bajaj, Priyanka ^a   Tripathy, Rajan K ^a   Pande, Abhay H ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Mono PEGylation; Organophosphate; Protease digestion; rSsoPox; Thermostability

Indexed keywords

MACROGOL; PROTEINASE; RECOMBINANT ENZYME; RECOMBINANT SSOPOX; UNCLASSIFIED DRUG; AMIDASE; BACTERIAL PROTEIN; MACROGOL DERIVATIVE; PHOSPHOTRIESTERASE; RECOMBINANT PROTEIN; TRYPSIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME ISOLATION; ENZYME MODIFICATION; ENZYME STABILITY; IN VITRO STUDY; ION EXCHANGE CHROMATOGRAPHY; NONHUMAN; ORGANOPHOSPHATE POISONING; PHYSICAL RESISTANCE; REACTION TIME; SITE SPECIFIC PEGYLATION; SULFOLOBUS SOLFATARICUS; CHEMISTRY; ENZYMOLOGY; METABOLISM;

AMIDOHYDROLASES; BACTERIAL PROTEINS; ENZYME STABILITY; PHOSPHORIC TRIESTER HYDROLASES; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; SULFOLOBUS SOLFATARICUS; TRYPSIN;

EID: 84947919141     PISSN: 09298665     EISSN: 18755305     Source Type: Journal    
DOI: 10.2174/0929866522666151002122751     Document Type: Article

References (27)

1. Bloch-Shilderman, E.; Rabinovitz, I.; Egoz, I.; Raveh, L.; Allon, N.; Grauer, E.; Gilat, E.; Weissman, B.A. Subchronic exposure to low-doses of the nerve agent VX: Physiological, behavioral, histo-pathological and neurochemical studies. Toxicol. Appl. Pharmacol. 2008, 231, 17-23.
2. Bajgar, J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem. 2004, 38, 151-216.
3. Lenz, D.E.; Yeung, D.; Smith, J.R.; Sweeney, R.E.; Lumley, L.A.; Cerasoli, D.M. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review. Toxicology 2007, 233, 31-39.
4. Rochu, D.; Chabriere, E.; Masson, P. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning. Toxicology 2007, 233, 47-59.
5. diTargiani, R.C.; Chandrasekaran, L.; Belinskaya, T.; Saxena, A. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity. Chem. Biol. Interact. 2010, 187, 349-354.
6. Merone, L.; Mandrich, L.; Rossi, M.; Manco, G. A thermostable phosphotriesterase from the archaeon Sulfolobus solfataricus: cloning, over expression and properties. Extremophiles 2005, 9, 297-305.
7. Elias, M.; Dupuy, J.; Merone, L.; Mandrich, L.; Porzio, E.; Moniot, S.; Rochu, D.; Lecomte, C.; Rossi, M.; Masson, P.; Manco, G.; Chabriere, E. Structural basis for natural lactonase and promiscuous phosphotriesterase activities. J. Mol. Biol. 2008, 379, 1017-1028.
8. Hiblot, J.; Gotthard, G.; Chabriere, E.; Elias, M. Characterization of the organophosphate hydrolase catalytic activity of SsoPox. Sci. Rep. 2012, 2, 779.
9. Merone, L.; Mandrich, L.; Porzio, E.; Rossi, M.; Müller, S.; Reiter, G.; Worek, F.; Manco, G. Improving the promiscuous nerve agent hydrolase activity of a thermostable archaeal lactonase. Biore-source Technol. 2010, 101, 9204-9212.
10. Mandrich, L.; Merone, L.; Manco, G. Hyperthermophilic phosphot-riesterases/lactonases for the environment and human health. Environ. Technol. 2010, 31, 1115-1127.
11. Sun, W.; Luo, C.; Tipparaju, P.; Doctor, B.P.; Saxena, A. Effect of polyethylene glycol conjugation on the circulatory stability of plasma-derived human butyrylcholinesterase in mice. Chem. Biol. Interact. 2013, 203, 172-176.
12. Mero, F.M. The impact of PEGylation on biological therapies. BioDrugs 2008, 22, 315-329.
13. Pasut, G.; Veronese, F.M. State of the art in PEGylation: the great versatility achieved after forty years of research. J. Control. Re-lease. 2012, 161, 461-72.
14. Roberts, M.J.; Bentley, M.D.; Harris, J.M. Chemistry for peptide and protein PEGylation. Adv. Drug. Deliver. Rev. 2012, 64, 116-127.
15. Kinstler, O.B.; Brems, D.N.; Lauren, S.L.; Paige, A.G.; Hamburger, J.B.; Treuheit, M.J. Characterization and stability of N-terminally PEGylated rhG-CSF. Pharm Res. 1996, 13, 996-1002.
16. Kinstler, O.; Molineux, G.; Treuheit, M.; Ladd, D.; Gegg, C. Mono-N-terminalpoly (ethylene glycol)-protein conjugates. Adv. Drug. Deliver. Rev. 2002, 54, 477-485.
17. Liu, R.; Li, D.; Wang, J.; Qiu, R.; Lin, Q.; Zhang, G.; Ma, G.; Su, Z.; Hu, T. Preparation, characterization and in vitro bioactivity of N-terminally PEGylated staphylokinase dimers. Process Biochem. 2012, 47, 41-46.
18. Bajaj, P.; Aggarwal, G.; Tripathy, R.K.; Pande, A.H. Interplay between amino acid residues at positions 192 and 115 in modulating hydrolytic activities of human paraoxonase 1. Biochimie 2014, 105, 202-210.
19. Maiser, B.; Kröner, F.; Dismer, F.; Brenner-Weiss, G.; Hubbuch, J. Isoform separation and binding site determination of mono-PEGylated lysozyme with pH gradient chromatography. J. Chro-matogr. A 2012, 1268, 102-108.
20. Hu, J.; Sebald, W. N-terminal specificity of PEGylation of human bone morphogenetic protein-2 at acidic pH. Int. J. Pharm. 2011, 413, 140-146.
21. Bernkop-Schnurch, A. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J. Control. Release 1998, 52, 1-16.
22. Whitcomb D.C.; Lowe M.E. Human pancreatic digestive enzymes. Dig. Dis. Sci. 2007, 52, 1-17.
23. Harris J.M.; Chess R.B. Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Disc. 2003, 2, 214-221.
24. Chilukuri N.; Parikh K.; Sun W.; Naik R.; Tipparaju P.; Doctor B.P.; Saxena A. Polyethylene glycosylation prolongs the circulatory stability of recombinant human butyrylcholinesterase. Chem. Biol. Interact. 2005, 157-158, 115-121.
25. Freitas Dda, S.; Abrahao-Neto, J. Biochemical and biophysical characterization of lysozyme modified by PEGylation. Int. J. Pharm. 2010, 392, 111-117.
26. Monfardini, C.; Shiavon, O.; Caliceti, P.; Mopurgo, M.; Harris, J.M.; Veronese, F.M. A branched monomethoxypoly (ethylene gly-col) for protein modification. Bioconjugate Chem. 1995, 6, 62-69.
27. Soares, L.S.; Guimaraes, G.M.; Polakiewicz, B.; Pitombo, R.N.M.; Abrahao-Neto, J. Effects of polyethylene glycol attachment on physicochemical and biological stability of E. coli l-asparaginase. Int. J. Pharm. 2002, 237, 163-170.